Company
Every investor coverage indicates participated in a round StemoniX raised.
Companies StemoniX acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| David Buché | Vice President of Sales (former) | Brandon BioCatalyst portfolio |
Stories naming StemoniX. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Parkinson's monitoring company Global Kinetics is launching its PKG wearable into the US remote physiologic monitoring market and has recruited David Buché as vice president of sales to lead the American commercial push.